Zura Bio to Participate in the Cantor Global Healthcare Conference
Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating autoimmune and inflammatory diseases, today announced that members of its management team will participate in the following upcoming investor conference:
Cantor Global Healthcare Conference
Location: New York, NY
Fireside chat: Wednesday, September 9, 2026, at 9:10 a.m. ET
